Dose efficace en bolus de remimazolam pour l’insertion de l’i-gel® chez la patientèle non paralysée : une étude de détermination de dose
Crossref DOI link: https://doi.org/10.1007/s12630-024-02762-w
Published Online: 2024-04-26
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cho, Eunah
Roh, Yun Ho
Moon, Jisu
Kim, Yangjin
Shin, Seokyung http://orcid.org/0000-0002-2641-0070
Funding for this research was provided by:
Hana Pharm Co., Ltd.
Text and Data Mining valid from 2024-04-26
Version of Record valid from 2024-04-26
Article History
Received: 5 July 2023
Revised: 19 February 2024
Accepted: 2 March 2024
First Online: 26 April 2024